Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of Tailoring Ablation Index to Left Atrial Wall Thickness During Atrial Fibrillation Ablation: The Ablate By-LAW Study

NCT04218604 is registered in ClinicalTrials.gov with Centro Medico Teknon as lead sponsor.

NCT NCT04218604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of Tailoring Ablation Index to Left Atrial Wall Thickness During Atrial Fibrillation Ablation: The Ablate By-LAW Study
Lead sponsor
Centro Medico Teknon
Phase
Not applicable
Overall status
Completed
Start date
November 21, 2020
Completion date
July 20, 2022
Enrollment
106 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation